Utility of CC7 Transfer in Stroke Subtypes
Seventh Cervical Nerve Transfer for Spastic Arm Paresis: A Prospective Analysis of Efficacy in Ischemic vs. Hemorrhagic Stroke
1 other identifier
interventional
95
1 country
1
Brief Summary
The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2022
CompletedFirst Submitted
Initial submission to the registry
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
February 27, 2026
February 1, 2026
5 years
August 14, 2023
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in arm function, as measured by the Fugl-Meyer upper-extremity scale.
The Fugl-Meyer is a widely used and highly recommended stroke-specific, performance-based measure of impairment with 5 domains and a possible 226 points.
12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery.
Study Arms (1)
Contralateral C7 root transfer for the treatment of spastic hemiparesis.
EXPERIMENTALThe C7 nerve root transfer will occur to the patients on this arm.
Interventions
Performing surgery to transfer the C7 nerve to treat stroke patients experiencing spastic hemiparesis.
Eligibility Criteria
You may qualify if:
- History of ischemic or hemorrhagic stroke with resultant arm paresis that has ceased to improve within 1-5 years of rehabilitation.
- baseline Fugl-Meyer score below 33
You may not qualify if:
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Health
Lebanon, New Hampshire, 03677, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Hong, Dr.
Dartmouth-Hitchcock Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 14, 2023
First Posted
August 21, 2023
Study Start
March 13, 2022
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
February 27, 2026
Record last verified: 2026-02